The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology. The study looked at the drug ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

Some of the most exciting advances in migraine treatment technology aren’t medications but devices. The U.S. Food and Drug Administration (FDA) recently cleared a new neuromodulation device ...

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment, according to a recent study published in Neurology. "With many current drugs to prevent migraine, it ...

Triptans is a medication that can help relieve migraine symptoms. Research has found it effective, but it’s not for everyone. Migraine is a neurological condition affecting millions of people ...

Dec. 23, 2024 — A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related ...

Pfizer will pay nearly $60 million to settle allegations that Biohaven, a company it acquired, paid kickbacks to healthcare ...

THURSDAY, Dec. 26, 2024 (HealthDay News) -- Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent their terrible symptoms. But a recently ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. Triptans are highly effective for short-term treatment of acute migraine attacks. They are effective in MA or MO, but are not intended for use in ...